The global Dialysis Market is valued at USD 97.5 Billion in 2023 and is projected to reach a value of USD 430.8 Billion by 2032 at a CAGR (Compound Annual Growth Rate) of 7.7% between 2024 and 2032.

Key Highlights of Dialysis Market

• North America predominantly led the Dialysis market in 2023, with 39.4% of the total market share
• Aisa Pacific is projected to remain the fastest-growing region during the forecast period
• The Hemodialysis (HD) segment significantly contributed to the market’s expansion, constituting over 80.5% of the overall revenue share in 2023
• The Services segment played a substantial role in driving the market’s growth in 2023, with 57.4% of share
• The Dialysis Centers and Hospitals segment took the lead in the market, with 75.2% of revenue in 2023
• B. Brauns green Dialysis initiative, exemplified in their Teplice facility, innovatively balances patient care with environmental sustainability. Amidst Europes growing demand for renal replacement therapy, this initiative prioritizes resource efficiency and waste reduction. As a beacon of sustainable healthcare, it sets a precedent for responsible medical facilities across the continent
• In the United Kingdom, approximately 68,249 patients are undergoing Renal Replacement Therapy (RRT). Transplantation emerges as the predominant treatment modality (57%), followed by Hemodialysis (HD) in 35.4% and peritoneal Dialysis (PD) in 5.6% of RRT cases. Among the HD population, 2% opt for home Hemodialysis (HHD)

{{bar_graph}}

Dialysis Market: Regional Overview

In 2023, the North American Dialysis market asserted significant dominance, capturing 39.4% of the revenue share. This prominence aligns with the staggering prevalence of kidney disease in the region, affecting approximately 37 million Americans. Alarmingly, over 556,000 Americans rely on Dialysis for renal support. Compounding this issue is the lack of awareness surrounding kidney disease, with 9 out of 10 individuals unaware of their condition. Moreover, approximately 1 in 3 people with significantly diminished kidney function remain oblivious to their condition until it progresses. Given the scarcity of available donor kidneys, the majority of individuals facing kidney failure resort to Dialysis for treatment. In 2021, out of the 135,000 Americans newly diagnosed with kidney failure, nearly 97% began Dialysis, while a mere 4,153 managed to secure a preemptive kidney transplant.

U.S. Dialysis Market Overview

In 2023, the Dialysis market in the United States boasted a valuation of USD 31.5 Billion, poised to ascend to approximately USD 62.7 Billion by 2032. Forecasts predict a noteworthy Compound Annual Growth Rate (CAGR) of 8% from 2024 to 2032, underlining the sectors robust expansion. Fresenius Medical Care (FME) stands at the forefront, representing global leadership in medical device and membrane engineering technologies, as it introduces industry-leading Dialysis Therapy to U.S. kidney disease patients. With the recent U.S. Food and Drug Administration (FDA) 510(k) clearance for the company’s 5008X Hemodialysis System, FME extends its pioneering Hv-HDF Dialysis therapy, already prevalent in Europe, to the American market. This milestone not only initiates clinical evaluations and user-studies in the U.S. but also sets the stage for a comprehensive commercial launch of the 5008X Hemodialysis System in 2025.

{{CountryImage}}

The global Dialysis market can be categorized as Type, Product And Services, End User, and Region.

Dialysis Market: Type Overview

In 2023, substantial expansion was observed in the Global Dialysis market within the Hemodialysis (HD) category with 80.5% of revenue. Based on the Type, the Dialysis market is bifurcated into Hemodialysis (HD) and Peritoneal Dialysis (PD). The Hemodialysis (HD) segment within the Global Dialysis Market is a critical component in the treatment of kidney failure worldwide. Hemodialysis involves the removal of waste products & excess fluids from the blood by means of a Dialysis machine, effectively performing the functions of the kidneys in individuals with renal impairment. With a significant portion of the global population affected by kidney disease, the demand for Hemodialysis is progressively increasing.

Dialysis Market: Product And Services Overview

There was significant growth in the Services segment in 2023, constituting over 57.4% of market share. Based on the Product And Services, the Dialysis market is segmented into Equipment, Consumables, Dialysis Drugs, and Services. The services segment plays a vital role with regard to the provision of comprehensive care and support for patients who are receiving Dialysis treatment worldwide. They include a wide range of services, such as the management of Dialysis centers, education for patients and advice on nutrition and psychosomatic support. In addition, home Dialysis education and support services are becoming increasingly common which enable patients to take care of their treatment in the comfort of their houses.

Dialysis Market: End User Overview

In 2023, there was noteworthy growth in the Dialysis Centers and Hospitals segment, i.e., 75.2% of market revenue. Based on the End User, the Dialysis market is divided into Dialysis Centers & Hospitals and Home Care. The Dialysis Centres and Hospitals segment is the cornerstone of the global Dialysis market, providing essential facilities for renal replacement therapy to patients who are suffering from kidney failure. These facilities and hospitals are equipped with cutting-edge Dialysis machines, staffed by qualified healthcare professionals such as nephrologists, nurses or technicians who oversee the Dialysis process in order to ensure patient safety and comfort. Demand for Dialysis services is on the rise due to a growing incidence of kidney disease around the world, leading to an expansion in this area.

Key Trends

1. Rapid technological progress has led to the development of more efficient and patient friendly Dialysis machines and equipment in the Dialysis industry. Innovations are gaining traction, such as wearable artificial kidneys, improved Hemodialysis machines, and home Dialysis solutions.
2. The rise in incidence of chronic kidney diseases, diabetes, hypertension, and other lifestyle-related disorders is fueling the demand for Dialysis treatments worldwide. As the aging population grows and healthcare infrastructure improves in emerging markets, the number of patients requiring Dialysis is expected to rise.
3. The factors which have led to a significant shift towards home Dialysis therapy are convenience, cost effectiveness, patient desire for greater autonomy and independence. Home Hemodialysis and peritoneal Dialysis offer flexibility in treatment schedules and reduce the burden of frequent hospital visits.
4. In response to the increasing demand for Dialysis services, there is a trend towards the establishment of high-volume Hemodialysis centers. To provide effective and excellent care to a large number of patients, these centers have advanced technology as well as specially trained healthcare professionals on staff.
5. Peritoneal Dialysis is becoming increasingly favored as a substitute for Hemodialysis, especially among individuals with end-stage renal disease. The increasing acceptance of peritoneal Dialysis globally is fueled by factors like decreased infrastructure needs, less stringent dietary limitations, and the convenience of administering treatments at home.
6. Sustainability initiatives aimed at reducing water consumption, energy use and waste generation related to Dialysis treatment are becoming increasingly important in the Dialysis industry. In order to minimize the environmental impact of Dialysis treatment, manufacturers and healthcare providers are looking at environmentally friendly technologies and practices.

Premium Insights

Since its successful introduction in the 1940s, Dialysis has been a major development and as of the 1970s it had become standard treatment for kidney failure. With millions of patients benefiting from these treatments globally, the Dialysis market is dynamically shaped by various factors. The flexibility of Dialysis modalities, such as Hemodialysis (HD) and peritoneal Dialysis (PD), each catering to individual patient needs and preferences, influences the market landscape. HD, accounting for 88% of Dialysis patients worldwide, involves a dialyzer machine filtering blood outside the body, typically performed in a Dialysis center or at home. In contrast, PD offers an alternative where the patients abdomen acts as a natural filter, providing flexibility in treatment location. Innovations in Dialysis care delivery models, such as telemedicine for remote monitoring and support, and initiatives promoting home-based Dialysis options, contribute to market expansion and patient-centric care approaches.

{{dashboard_image}}

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

The global Dialysis market is undergoing significant transformation with the emergence of Mozarc Medical, a joint venture between Medtronic and DaVita, introduced in April 2023. This collaborative effort signifies a pivotal step towards revolutionizing kidney health by prioritizing patient-centered technology solutions. Mozarc Medical is poised to lead the industry with its commitment to innovation, aiming to enhance the overall patient experience and expand access to care on a global scale. As patient preferences evolve and the demand for in-home kidney care grows, Mozarc Medicals establishment couldn't be timelier, positioning it uniquely to cater to the diverse needs of kidney disease patients worldwide. Central to its mission is a global workforce comprising the former Medtronic Renal Care Solutions (RCS) business, along with top-tier talent recruited to drive the companys strategic objectives forward.

B. Brauns acquisition of Intermedt Medizin & Technik GmbH marks a significant development in the global Dialysis market. By integrating Intermedt into its B. Braun Avitum division, B. Braun expands its product portfolio and becomes a comprehensive system provider of extracorporeal blood transfusion, in particular Dialysis. With the addition of Intermedts fully automated ECOMix mixing system, Dialysis centers are revolutionizing their operation, simplifying the preparation of acid concentrates required for Hemodialysis, while offering flexibility and environmental sustainability. In order to optimise the efficiency and free up precious time for treatment and care, ECOMix is accelerating Dialysis by ensuring seamless synchronization and automation of all elements. In addition, in line with industrys growing focus on sustainable Dialysis treatment, the mixing of concentrates at site has been shown to reduce transport emissions as well as plastic waste.

Competitive Landscape

Major companies in the market are significantly focusing on partnerships and collaborations, mergers and acquisitions, and new product launch. For instance, Nipro Medical Corporation (Nipro), a prominent provider of renal, vascular, and medical-surgical products, unveiled the SURDIAL™ DX Hemodialysis System for the U.S. market in March 2022. The SURDIAL™ DX system represents cutting-edge technology aimed at enhancing the Dialysis experience for both patients and clinicians. Manufactured in Japan, it benefits from over three decades of renal device innovation expertise from Nipro Corporation, Nipros parent company.

Recent Market Developments

• In March 2024, Fresenius Medical Care, the leading provider of renal disease products and services globally, disclosed the divestment of its Dialysis clinic networks in Brazil, Colombia, Chile, and Ecuador to DaVita Inc. for a total transaction value of USD 300 million. Pending regulatory approvals in Brazil, Colombia, and Ecuador, these transactions mark significant progress in Fresenius Medical Cares portfolio optimization strategy, with the closure of each transaction anticipated throughout 2024.
• In March 2024, Diaverum Spain opens the doors to its latest facility, the Badalona Dialysis Centre. Spanning across an area exceeding 1,200 square meters, the center comprises five rooms equipped with 40 stations capable of accommodating up to 240 patients. Its primary emphasis is on providing Hemodialysis services, delivered through Diaverum’s standardized, proprietary care delivery model, and bolstered by a robust digital infrastructure.
• In December 2023, Diaverum expanded its home Dialysis service for Hamburg patients by introducing an additional mobile device. Patients in Hamburg now have the option of selecting an innovative compact device alongside peritoneal Dialysis (PD) and traditional home Hemodialysis with a conventional center machine. The Physidia S3 Monitor facilitates Hemodialysis with a mobile device at home or while on the move.
• In September 2023, B. Braun Medical Inc. (B. Braun) secured FDA 510(k) clearance for its AQUAbase nX Reverse Osmosis System. A single-stage reverse osmosis device, AQUAbase nX delivers high-quality water for Dialysis patients without the need for chemical additives. With its innovative design, AQUAbase nX boasts up to a 75% raw water conversion rate, potentially conserving water usage and reducing power, pre-treatment, and equipment maintenance costs.
• In June 2023, AngioDynamics announced the sale of its Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 million. AngioDynamics Inc., a prominent medical technology company dedicated to enhancing vascular system health, broadening cancer treatment options, and enhancing patient quality of life, disclosed the completion of this transaction. The sale includes AngioDynamics’ DuraFlow™, DuraMax®, Evenmore®, Schon XL®, Trio-CT®, and Vaxel Plus Hemodialysis Catheter brands, as well as the BioSentry™ Tract Sealant System Biopsy brand. This combined portfolio contributed approximately $32 million in sales during AngioDynamics’ Fiscal Year 2023.

​